Study of the specifics of the formation of IgG and IgM antibodies to low  molecular weight substances (synthetic cannabinoids and antidepressants) in  laboratory mice

Polyarush Svetlana Vitalyevna; Aripova Tamara; Pulatova Lola; Jalilov Fazliddin

Vol. 2 No. 2 (2024), Articles

Vol. 2 No. 2 (2024)

Study of the specifics of the formation of IgG and IgM antibodies to low molecular weight substances (synthetic cannabinoids and antidepressants) in laboratory mice

Articles

Published 2024-02-25

Polyarush Svetlana Vitalyevna⁺⁻
Aripova Tamara⁺⁻
Pulatova Lola⁺⁻
Jalilov Fazliddin⁺⁻

Polyarush Svetlana Vitalyevna

Institute of Immunology and Human Genomics

Aripova Tamara

Institute of Immunology and Human Genomics

Pulatova Lola

Alfraganus University

Jalilov Fazliddin

Alfraganus University

PDF

DOI

Keywords

Law molecular weight substances, antidepressants, synthetic cannabinoids antibodies, metabolizm

How to Cite

Polyarush Svetlana Vitalyevna, Aripova Tamara, Pulatova Lola, & Jalilov Fazliddin. (2024). Study of the specifics of the formation of IgG and IgM antibodies to low molecular weight substances (synthetic cannabinoids and antidepressants) in laboratory mice. Journal of Science-Innovative Research in Uzbekistan, 2(2), 492–502. Retrieved from https://universalpublishings.com/index.php/jsiru/article/view/4543

Abstract

The article provides experimental data from immunological studies conducted on mice regarding the formation of antibodies. Тhe results obtained allow us to establish the maximum accumulation of antibodies. It has been shown that the circulation of specific antibodies is maintained at a detectablee level. We can conclude that the most significant for diagnising the use of psychotropic substances is the identification of class antibodies JgM

PDF

DOI

References

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) // URL: http://www.emcdda.europa.eu

Kurdil N.V. Actual issues of toxicology and laboratory identification of synthetic cannabinoids // Medicine of emergency conditions. .- 2015. - T. - 65. - P. 35-45

Kraemer, T.; Maurer, H. Toxicokinetics of amphetamines: Metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their Nalkyl derivatives. Ther. Drug Monit. 2002, 24, 277-289

Temerdashev A.Z. Screening and determination of certain narcotic and psychotropic substances in materials of natural and synthetic origin by chromatographic methods // Materials of the All-Russian Conf. on analytical spectroscopy: Abstracts. - Krasnodar., - 2012 .- P.208-210

Weksler, M.E., Cherubin, C., Kilcoyne, M., Koppel, G., Yoel, M., 1973. Absence of morphine-binding activity in serum from heroin addicts. Clin. Exp. Immunol. 13, 613–617

Herndon, B.L., Baeder, D.H., Ringle, D.A., 1976. Specific serum binding of morphine, levorphanol and heroin. Clin. Exp. Immunol. 23, 367–372

De Cato, L. Jr., Adler, F.L., 1973. Neutralisation of morphine activity by antibody. Res. Commun. Chem. Pathol. Pharmacol. 5, 775–788

Martinez, F., Watson, R.R., 1990. Effects of cocaine and morphine on IgG production by human peripheral blood lymphocytes in vitro. Life Sci. 47, 59–64.

Gamaleya, N., Tronnikov, S., Ulyanova, L., Klimova, S., Dmitrieva, I.,1996. Antibodies to morphine as indicators of chronic morphine intoxication and impaired immune reactivity. Addict. Biol. 1, 437–445

Myagkova M.A., Abramenko T.V., Epshtein O.I., Morozova V.I. Enzymelinked immunosorbent assay of antibodies to opiates in the blood serum of drug addicts to assess the effectiveness of therapy with the drug "ANAR" // Narcology, 2006. - No. 3. - P.53-55

Ngo T., Lenhoff G. Enzyme-linked immunosorbent assay; 1988 World; 1988; 446 p